The neurobeachin-like 2 protein regulates mast cell homeostasis

Journal of Immunology

Volumn 199, Issue 8, 2017, Pages 2948-2957

  Drube, Sebastian ^a   Grimlowski, Randy ^a   Deppermann, Carsten ^b,d   Fröbel, Julia ^c   Kraft, Florian ^a,e   Andreas, Nico ^a   Stegner, David ^b   Dudeck, Jan ^c   Weber, Franziska ^a   Rödiger, Mandy ^a   Göpfert, Christiane ^a   Drube, Julia ^a   Reich, Daniela ^a   Nieswandt, Bernhard ^b   Dudeck, Anne ^c   Kamradt, Thomas ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Institute of Molecular and Clinical Immunology   (Germany)

^d UNIVERSITY OF CALGARY   (Canada)

^e RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; FC EPSILON RI PROTEIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERLEUKIN 6; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROBEACHIN LIKE 2 PROTEIN; NUCLEAR PROTEIN; PROTEIN P27; PROTEIN TYROSINE PHOSPHATASE SHP 1; STAT5 PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR GATA 2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; GATA2 PROTEIN, MOUSE; INTERFERON REGULATORY FACTOR; NBEAL2 PROTEIN, MOUSE; PLASMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DOWN REGULATION; HOMEOSTASIS; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BLEEDING; CELL CULTURE; CELL CYCLE; CELL GRANULE; GENETICS; GRAY PLATELET SYNDROME; KNOCKOUT MOUSE; MEGAKARYOCYTE; METABOLISM; MUTATION; PHYSIOLOGY; SPLENOMEGALY; THROMBOCYTOPENIA;

ANIMALS; BLOOD PROTEINS; CELL CYCLE; CELLS, CULTURED; CYTOPLASMIC GRANULES; GATA2 TRANSCRIPTION FACTOR; GRAY PLATELET SYNDROME; HEMORRHAGE; INTERFERON REGULATORY FACTORS; MAST CELLS; MEGAKARYOCYTES; MICE; MICE, KNOCKOUT; MUTATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; PROTO-ONCOGENE PROTEINS C-KIT; SIGNAL TRANSDUCTION; SPLENOMEGALY; STAT5 TRANSCRIPTION FACTOR; THROMBOCYTOPENIA;

EID: 85031506866     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1700556     Document Type: Article

References (41)

1. Cullinane, A. R., A. A. Schäffer, and M. Huizing. 2013. The BEACH is hot: a LYST of emerging roles for BEACH-domain containing proteins in human disease. Traffic 14: 749-766.
2. Burgess, A., J. P. Mornon, G. de Saint-Basile, and I. Callebaut. 2009. A concanavalin A-like lectin domain in the CHS1/LYST protein, shared by members of the BEACH family. Bioinformatics 25: 1219-1222.
3. Harlan, J. E., P. J. Hajduk, H. S. Yoon, and S. W. Fesik. 1994. Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature 371: 168-170.
4. Gunay-Aygun, M., T. C. Falik-Zaccai, T. Vilboux, Y. Zivony-Elboum, F. Gumruk, M. Cetin, M. Khayat, C. F. Boerkoel, N. Kfir, Y. Huang, et al. 2011. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet a-granules. Nat. Genet. 43: 732-734.
5. Kahr, W. H., J. Hinckley, L. Li, H. Schwertz, H. Christensen, J. W. Rowley, F. G. Pluthero, D. Urban, S. Fabbro, B. Nixon, et al. 2011. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat. Genet. 43: 738-740.
6. Albers, C. A., A. Cvejic, R. Favier, E. E. Bouwmans, M. C. Alessi, P. Bertone, G. Jordan, R. N. Kettleborough, G. Kiddle, M. Kostadima, et al. 2011. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nat. Genet. 43: 735-737.
7. Breton-Gorius, J., W. Vainchenker, A. Nurden, S. Levy-Toledano, and J. Caen. 1981. Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. Am. J. Pathol. 102: 10-19.
8. Nurden, A. T., and P. Nurden. 2014. Congenital platelet disorders and understanding of platelet function. Br. J. Haematol. 165: 165-178.
9. St John, A. L., and S. N. Abraham. 2013. Innate immunity and its regulation by mast cells. J. Immunol. 190: 4458-4463.
10. Sibilano, R., B. Frossi, and C. E. Pucillo. 2014. Mast cell activation: a complex interplay of positive and negative signaling pathways. Eur. J. Immunol. 44: 2558-2566.
11. Dudeck, A., J. Dudeck, J. Scholten, A. Petzold, S. Surianarayanan, A. Köhler, K. Peschke, D. Vöhringer, C. Waskow, T. Krieg, et al. 2011. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34: 973-984.
12. Tsai, M., L. S. Shih, G. F. Newlands, T. Takeishi, K. E. Langley, K. M. Zsebo, H. R. Miller, E. N. Geissler, and S. J. Galli. 1991. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J. Exp. Med. 174: 125-131.
13. Ma, P., R. S. Mali, V. Munugalavadla, S. Krishnan, B. Ramdas, E. Sims, H. Martin, J. Ghosh, S. Li, R. J. Chan, et al. 2011. The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor. Blood 118: 3459-3469.
14. Shelburne, C. P., M. E. McCoy, R. Piekorz, V. Sexl, K. H. Roh, S. M. Jacobs-Helber, S. R. Gillespie, D. P. Bailey, P. Mirmonsef, M. N. Mann, et al. 2003. Stat5 expression is critical for mast cell development and survival. Blood 102: 1290-1297.
15. Hu, P., N. Carlesso, M. Xu, Y. Liu, A. R. Nebreda, C. Takemoto, and R. Kapur. 2012. Genetic evidence for critical roles of P38a protein in regulating mast cell differentiation and chemotaxis through distinct mechanisms. J. Biol. Chem. 287: 20258-20269.
16. Löhning, M., A. Stroehmann, A. J. Coyle, J. L. Grogan, S. Lin, J. C. Gutierrez-Ramos, D. Levinson, A. Radbruch, and T. Kamradt. 1998. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 95: 6930-6935.
17. Moritz, D. R., H. R. Rodewald, J. Gheyselinck, and R. Klemenz. 1998. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J. Immunol. 161: 4866-4874.
18. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
19. Ho, L. H., T. Ohno, K. Oboki, N. Kajiwara, H. Suto, M. Iikura, Y. Okayama, S. Akira, H. Saito, S. J. Galli, and S. Nakae. 2007. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J. Leukoc. Biol. 82: 1481-1490.
20. Deppermann, C., D. Cherpokova, P. Nurden, J. N. Schulz, I. Thielmann, P. Kraft, T. Vogtle, C. Kleinschnitz, S. Dutting, G. Krohne, et al.2013. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J. Clin. Invest. 123: 3331-3342.
21. Sasaki, T., T. Wada, H. Kishimoto, J. Irie-Sasaki, G. Matsumoto, T. Goto, Z. Yao, A. Wakeham, T. W. Mak, A. Suzuki, et al. 2001. The stress kinase mitogenactivated protein kinase kinase (MKK)7 is a negative regulator of antigen receptor and growth factor receptor-induced proliferation in hematopoietic cells. J. Exp. Med. 194: 757-768.
22. Tipping, A. J., C. Pina, A. Castor, D. Hong, N. P. Rodrigues, L. Lazzari, G. E. May, S. E. Jacobsen, and T. Enver. 2009. High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle. Blood 113: 2661-2672.
23. Ezoe, S., I. Matsumura, S. Nakata, K. Gale, K. Ishihara, N. Minegishi, T. Machii, T. Kitamura, M. Yamamoto, T. Enver, and Y. Kanakura. 2002. GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. Blood 100: 3512-3520.
24. Lekmine, F., C. K. Chang, N. Sethakorn, T. K. Das Gupta, and G. I. Salti. 2007. Role of microphthalmia transcription factor (Mitf) in melanoma differentiation. Biochem. Biophys. Res. Commun. 354: 830-835.
25. Li, Y., X. Qi, B. Liu, and H. Huang. 2015. The STAT5-GATA2 pathway is critical in basophil and mast cell differentiation and maintenance. J. Immunol. 194: 4328-4338.
26. Sasaki, H., D. Kurotaki, N. Osato, H. Sato, I. Sasaki, S. Koizumi, H. Wang, C. Kaneda, A. Nishiyama, T. Kaisho, et al. 2015. Transcription factor IRF8 plays a critical role in the development of murine basophils and mast cells. Blood 125: 358-369.
27. Ando, T., W. Xiao, P. Gao, S. Namiranian, K. Matsumoto, Y. Tomimori, H. Hong, H. Yamashita, M. Kimura, J. Kashiwakura, et al. 2014. Critical role for mast cell Stat5 activity in skin inflammation. Cell Reports 6: 366-376.
28. Saitoh, S., R. Arudchandran, T. S. Manetz, W. Zhang, C. L. Sommers, P. E. Love, J. Rivera, and L. E. Samelson. 2000. LAT is essential for Fc(epsilon) RI-mediated mast cell activation. Immunity 12: 525-535.
29. Kawakami, Y., J. Kitaura, A. B. Satterthwaite, R. M. Kato, K. Asai, S. E. Hartman, M. Maeda-Yamamoto, C. A. Lowell, D. J. Rawlings, O. N. Witte, and T. Kawakami. 2000. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J. Immunol. 165: 1210-1219.
30. Hata, D., Y. Kawakami, N. Inagaki, C. S. Lantz, T. Kitamura, W. N. Khan, M. Maeda-Yamamoto, T. Miura, W. Han, S. E. Hartman, et al. 1998. Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. J. Exp. Med. 187: 1235-1247.
31. Saitoh, S., S. Odom, G. Gomez, C. L. Sommers, H. A. Young, J. Rivera, and L. E. Samelson. 2003. The four distal tyrosines are required for LAT-dependent signaling in FcepsilonRI-mediated mast cell activation. J. Exp. Med. 198: 831-843.
32. Guerrero, J. A., C. Bennett, L. van der Weyden, H. McKinney, M. Chin, P. Nurden, Z. McIntyre, E. L. Cambridge, J. Estabel, H. Wardle-Jones, et al. 2014. Gray platelet syndrome: proinflammatory megakaryocytes and a-granule loss cause myelofibrosis and confer metastasis resistance in mice. Blood 124: 3624-3635.
33. Föger, N., A. Jenckel, Z. Orinska, K. H. Lee, A. C. Chan, and S. Bulfone-Paus. 2011. Differential regulation of mast cell degranulation versus cytokine secretion by the actin regulatory proteins Coronin1a and Coronin1b. J. Exp. Med. 208: 1777-1787.
34. Olszewski, M. B., A. J. Groot, J. Dastych, and E. F. Knol. 2007. TNF trafficking to human mast cell granules: mature chain-dependent endocytosis. J. Immunol. 178: 5701-5709.
35. Nakayama, T., N. Mutsuga, L. Yao, and G. Tosato. 2006. Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells. J. Leukoc. Biol. 79: 95-104.
36. Kahr, W. H., R. W. Lo, L. Li, F. G. Pluthero, H. Christensen, R. Ni, N. Vaezzadeh, C. E. Hawkins, A. S. Weyrich, J. Di Paola, et al. 2013. Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. Blood 122: 3349-3358.
37. Esashi, E., Y. H. Wang, O. Perng, X. F. Qin, Y. J. Liu, and S. S. Watowich. 2008. The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 28: 509-520.
38. Masuda, A., K. Hashimoto, T. Yokoi, T. Doi, T. Kodama, H. Kume, K. Ohno, and T. Matsuguchi. 2007. Essential role of GATA transcriptional factors in the activation of mast cells. J. Immunol. 178: 360-368.
39. Zhou, J. S., W. Xing, D. S. Friend, K. F. Austen, and H. R. Katz. 2007. Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis. J. Exp. Med. 204: 2797-2802.
40. Gebrane-Younès, J., E. M. Cramer, L. Orcel, and J. P. Caen. 1993. Gray platelet syndrome. Dissociation between abnormal sorting in megakaryocyte alphagranules and normal sorting in Weibel-Palade bodies of endothelial cells. J. Clin. Invest. 92: 3023-3028.
41. Rensing-Ehl, A., U. Pannicke, S. Y. Zimmermann, M. R. Lorenz, B. Neven, I. Fuchs, U. Salzer, C. Speckmann, A. Strauss, E. Maab, et al. 2015. Gray platelet syndrome can mimic autoimmune lymphoproliferative syndrome. Blood 126: 1967-1969.